DRAM2 Acts as an Oncogene in Non-Small Cell Lung Cancer and Suppresses the Expression of P53

Journal of Experimental and Clinical Cancer Research- United Kingdom

doi 10.1186/s13046-019-1068-4

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

P53 and Angiogenesis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Hypoxia-Sensitive LINC01436 Is Regulated by E2F6 and Acts as an Oncogene by Targeting miR-30a-3p in Non-Small Cell Lung Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Management of Leptomeningeal Metastases in Non-Oncogene Addicted Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

FSTL1 Suppresses Tumor Cell Proliferation, Invasion and Survival in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2017English

Expression of the BCL-3 Proto-Oncogene Suppresses P53 Activation

Genes and Development
GeneticsDevelopmental Biology
2006English

P042 LincRNA00494 Suppresses Non-Small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression in a ceRNA Manner

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

GRK5 Functions as an Oncogenic Factor in Non-Small-Cell Lung Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Current Treatment Options in Oncology
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy